NCT03891914
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
- Locations
-
- Bordeaux University Hospital - Haut-Lévêque Pessac, France
Clinical trial condition
Myeloma Multiple
Explore clinical trials studying Myeloma Multiple. Study availability and eligibility vary by location and protocol.
31 public trials
17 recruiting studies
Myeloma Multiple trial results
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
- Locations
-
- Touzeau Cyrille Nantes, France
NCT05887206
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +17 more
- Locations
-
- CHU Dijon Dijon, France
- CHU de Limoges - Hôpital Dupuytren Limoges, France
- HCL- Croix Rousse Lyon, France
- Clinique Monticelli-Vélodrome Marseille, France
NCT05338047
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +15 more
- Locations
-
- Hospital Universitario Dr. José Eleuterio González Monterrey, Nuevo León, Mexico
NCT03964688
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +15 more
- Locations
-
- MUMC+ Maastricht, Limburg, Netherlands
NCT04760184
- Conditions
- Blood Protein Disorders, COVID-19, Cardiovascular Diseases, +32 more
- Locations
-
- Uppsala Universitet Uppsala, Sweden
NCT04065789
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +16 more
- Locations
-
- Haemek Medical Center Afula, Israel
- Barzilai Medical Center Ashkelon, Israel
- Soroka Medical Center Beersheba, Israel
- Bnai-Zion Medical Center Haifa, Israel
NCT04236063
- Conditions
- Blood Cancer, Blood Protein Disorders, Cardiovascular Diseases, +22 more
- Locations
-
- University Malaya Kuala Lumpur, Malaysia
NCT07085728
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
- Locations
-
- Alaska Oncology and Hematology LLC Anchorage, Alaska, United States
Active, Not Recruiting
Multicenter Phase 2 Study of Subcutaneous Isatuximab Plus Bortezomib, Lenalidomide and Dexamethasone in the Treatment of Newly Diagnosed Transplant Ineligible Multiple Myeloma
NCT05889221
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
- Locations
-
- CHU Poitiers Poitiers, France